Vision Restoration Program
Vision Loss
Key Facts
About Dandelion Science
Dandelion Science is an early-stage, private biotech pioneering a novel approach to treating brain disorders through its Generative Neuromodulation™ platform. The company leverages generative AI to design therapies that program neural network dynamics, seeking to move beyond the broad and often deleterious effects of conventional neurochemical treatments. Based in Zurich and Geneva with a corporate presence in Boston, Dandelion is building a strong research foundation through collaborations with prestigious institutions like the Wyss Center Geneva and EPFL. The company is currently in a pre-clinical, pre-revenue stage, focused on platform development and validating its core hypothesis that brain network dynamics can be precisely targeted and modulated.
View full company profile